XFOR
X4 Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Arthur Taveras sold $49K of X4 Pharmaceuticals, Inc.
Sold$49,417
$0.73Price
67,695Shares
−21%Stake
What XFOR did after the filing
- The stock from Fri, Nov 3 close, $28.38
- −26.3%
- S&P 500, same days
- +9.0%
Measured over 30 trading days, to the Dec 18 close.
Traded Wed, Nov 1. Filed Fri, Nov 3, 12:39 PM ET, during the session. Returns use the Nov 3 close and the Dec 18 close. Not investment advice.